The 7th Annual Global Generics & Biosimilars Awards take place 14 October 2020 at The 'Stella Polare' convention centre, Fiera Milano, Milan, Italy and we are now accepting entries!
The Global Generics & Biosimilars Awards reward ‘best practice’ across the generics, biosimilars and value added medicine industries, while at the same time encouraging improvements in every aspect of the way business is conducted.
Business development initiatives – such as through innovative product development, clever licensing deals or smart legal manoeuvres – are at the heart of the Global Generics & Biosimilars Awards.
Equally important will be recognising the industries’ best executives and leading companies.
Every Award will effectively underscore the efforts made by the global generics and biosimilars industries to make more affordable medicines available to more people everywhere.
We look forward to welcoming you at the Global Generics & Biosimilars Awards 2020 on 14 October 2020, 2020. The safety and experience of our customers and teams are always our top priority. As such, we’re closely monitoring developments with COVID-19. We are following all government and health authority advice and are working with our venue partners to put in place a number of enhanced safety and hygiene measures at Global Generics & Biosimilars Awards 2020 and ensure a good event for everyone. For any questions, please contact our event management team at Natalie Cornwell, email: firstname.lastname@example.org, Tel: +44 (0) 7827 993 776. We will keep this page updated as the situation changes.
We look forward to seeing you at Global Generics & Biosimilars Awards 2020 for what is always a great chance to build relationships, make new partnerships and celebrate our industry and its latest achievements.
The deadline for entries is 17 July 2020!
IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™️, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 67,000 employees, IQVIA conducts operations in more than 100 countries.
is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
Pharmaceutical, biotechnology, generic and medical device companies trust West and our ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. They share their commitment to improving health for patients worldwide.